Lyka Labs - Quaterly Results

26 May 2025 Evaluate
The March 2025 quarter revenue stood at Rs. 305.17 millions, up 13.09% as compared to Rs. 269.84 millions during the corresponding quarter last year.The Total Profit for the quarter ended March 2025 of Rs. 13.07 millions grew from Rs.-16.22 millionsOperating Profit saw a handsome growth to 41.30 millions from 26.05 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 305.17 269.84 13.09 1346.97 1063.96 26.60 1346.97 1063.96 26.60
Other Income 7.20 3.90 84.62 23.44 16.47 42.32 23.44 16.47 42.32
PBIDT 41.30 26.05 58.54 202.32 162.07 24.83 202.32 162.07 24.83
Interest 5.20 10.35 -49.76 23.04 47.98 -51.98 23.04 47.98 -51.98
PBDT 36.10 15.60 131.41 179.28 113.54 57.90 179.28 113.54 57.90
Depreciation 13.38 27.72 -51.73 64.53 122.87 -47.48 64.53 122.87 -47.48
PBT 22.72 -12.12 -287.46 114.75 -9.33 -1329.90 114.75 -9.33 -1329.90
TAX 9.65 4.10 135.37 32.47 13.37 142.86 32.47 13.37 142.86
Deferred Tax 3.45 0.55 527.27 5.23 -2.63 -298.86 5.23 -2.63 -298.86
PAT 13.07 -16.22 -180.58 82.28 -22.70 -462.47 82.28 -22.70 -462.47
Equity 356.90 330.90 7.86 356.90 330.90 7.86 356.90 330.90 7.86
PBIDTM(%) 13.53 9.65 40.19 15.02 15.23 -1.39 15.02 15.23 -1.39

Lyka Labs Share Price

77.80 1.34 (1.75%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×